본문으로 건너뛰기
← 뒤로

A comparative dosimetric study of hypofractionated radiotherapy with different target volume delineation approaches in breast cancer patients after implant-based reconstruction.

Frontiers in oncology 2025 Vol.15() p. 1552813

Ding L, Wang X, Zheng Z, Long J, Miao G, Yang T, Li S, Dong N, Gao L

📝 환자 설명용 한 줄

[PURPOSE] This study dosimetrically compares hypofractionated VMAT plans using the updated ESTRO-ACROP guidelines versus conventional delineation in patients undergoing immediate implant-based breast

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • p-value P < 0.05

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Ding L, Wang X, et al. (2025). A comparative dosimetric study of hypofractionated radiotherapy with different target volume delineation approaches in breast cancer patients after implant-based reconstruction.. Frontiers in oncology, 15, 1552813. https://doi.org/10.3389/fonc.2025.1552813
MLA Ding L, et al.. "A comparative dosimetric study of hypofractionated radiotherapy with different target volume delineation approaches in breast cancer patients after implant-based reconstruction.." Frontiers in oncology, vol. 15, 2025, pp. 1552813.
PMID 41568383

Abstract

[PURPOSE] This study dosimetrically compares hypofractionated VMAT plans using the updated ESTRO-ACROP guidelines versus conventional delineation in patients undergoing immediate implant-based breast reconstruction after mastectomy.

[METHODS] We retrospectively enrolled 22 patients with immediate implant-based reconstruction post-mastectomy (12 left-sided, 10 right-sided), treated between January 2022 and June 2025. All patients underwent CT simulation; those with left-sided cancer were positioned using deep inspiration breath-hold (DIBH), and those with right-sided cancer under free breathing. For each patient, conventional (C-TVD) and ESTRO-ACROP guideline-based (E-TVD) target volumes were independently delineated on the same CT dataset. Hypofractionated VMAT plans were designed using a 6-MV beam, single-isocenter, dual-arc technique, prescribing 40.05 Gy in 15 fractions to the planning target volume (PTV). All plans were normalized to ensure ≥95% PTV coverage by the prescribed dose. Dose-volume parameters for targets and organs at risk (OARs) were then compared between the two delineation approaches.

[RESULTS] The conformity index (CI) of E-TVD was inferior to that of C-TVD; however, E-TVD achieved superior 95% prescription dose coverage of the target volume. Compared with C-TVD, E-TVD resulted in significantly lower V and D to the ipsilateral lung, with differences reaching statistical significance (P < 0.05). For the heart, E-TVD was associated with significantly lower V, as well as lower D and D to the left anterior descending coronary artery (LAD), with all differences reaching statistical significance (P < 0.05). Subgroup analyses stratified by left versus right breast cancer revealed that in left breast cancer patients, E-TVD resulted in statistically significant reductions in ipsilateral lung V, V, and D; bilateral lung V; heart V; LAD D and D; and contralateral breast D (all P < 0.05). In right breast cancer patients, E-TVD was associated with significantly lower ipsilateral lung D and contralateral breast D (both P < 0.05).

[CONCLUSIONS] In patients with breast cancer who undergo total mastectomy followed by immediate implant-based breast reconstruction, the E-TVD approach confers superior protection to organs at risk.

같은 제1저자의 인용 많은 논문 (5)